A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

NCT01674361 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Bitopertin
DRUG: Placebo
DRUG: SSRI

Sponsor

Hoffmann-La Roche